Pralsetinib is a tyrosine kinase inhibitor used as an active pharmaceutical ingredient in the manufacture of oral medications. It is supplied as a research compound or pharmaceutical raw material for use in drug development and manufacturing processes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Pralsetinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Cyproterone
pharmaceutical raw material
Tafluprost
pharmaceutical raw material
Tafluprost acid
pharmaceutical raw material
Vonoprazan Fumarate
pharmaceutical raw material
The international HS code for Pralsetinib (CAS 2097132-94-8) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexane-1-carboxamide
GBLBJPZSROAGMF-SIYOEGHHSA-N
CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)N[C@@H](C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC
Sourcing Pralsetinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.